moxifloxacin has been researched along with phenylpropanolamine in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (phenylpropanolamine) | Trials (phenylpropanolamine) | Recent Studies (post-2010) (phenylpropanolamine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 1,861 | 369 | 222 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Anziano, R; Glue, P; Malhotra, BK; Mancuso, J; Sweeney, K; Wicker, P | 1 |
1 trial(s) available for moxifloxacin and phenylpropanolamine
| Article | Year |
|---|---|
Thorough QT study with recommended and supratherapeutic doses of tolterodine.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Benzhydryl Compounds; Cresols; Cross-Over Studies; Cytochrome P-450 CYP2D6; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Genotype; Heart Rate; Humans; Male; Middle Aged; Models, Statistical; Moxifloxacin; Muscarinic Antagonists; Phenylpropanolamine; Quinolines; Tolterodine Tartrate | 2007 |
1 other study(ies) available for moxifloxacin and phenylpropanolamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |